Danaher Corporation (DHR)
| Market Cap | 154.73B -10.0% |
| Revenue (ttm) | 24.57B +2.9% |
| Net Income | 3.61B -7.3% |
| EPS | 5.05 -4.5% |
| Shares Out | 706.90M |
| PE Ratio | 43.52 |
| Forward PE | 26.02 |
| Dividend | $1.28 (0.58%) |
| Ex-Dividend Date | Dec 26, 2025 |
| Volume | 5,627,894 |
| Open | 219.37 |
| Previous Close | 219.62 |
| Day's Range | 217.31 - 221.00 |
| 52-Week Range | 171.00 - 242.80 |
| Beta | 0.93 |
| Analysts | Strong Buy |
| Price Target | 250.56 (+14.47%) |
| Earnings Date | Jan 28, 2026 |
About DHR
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for man... [Read more]
Financial Performance
In 2025, Danaher's revenue was $24.57 billion, an increase of 2.90% compared to the previous year's $23.88 billion. Earnings were $3.61 billion, a decrease of -7.31%.
Financial StatementsAnalyst Summary
According to 17 analysts, the average rating for DHR stock is "Strong Buy." The 12-month stock price target is $250.56, which is an increase of 14.47% from the latest price.
News
Danaher Stock Plunge Does Not Represent A Good Entry Point
Danaher Stock Plunge Does Not Represent A Good Entry Point
Danaher Corporation (DHR) Q4 2025 Earnings Call Transcript
Danaher Corporation (DHR) Q4 2025 Earnings Call Transcript
Danaher Expects Gradual Improvement In End-Market Conditions
Danaher Corp (NYSE: DHR) on Wednesday reported fourth-quarter 2025 sales of $6.84 billion, up 4.5% year-over-year, beating the consensus of $6.81 billion.
Danaher forecasts 2026 profit in line with estimates on pharma spending recovery
Life sciences firm Danaher Corp forecast annual profit largely in line with Wall Street estimates on Wednesday and beat fourth-quarter profit and revenue expectations, as improving conditions in the p...
Danaher Reports Fourth Quarter and Full Year 2025 Results
WASHINGTON, Jan. 28, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the fourth quarter and full year 2025. All results in this release reflect only c...
Danaher Corporation (DHR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Danaher Corporation (DHR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Mar Vista U.S. Quality Q4 2025 Top Contributors And Detractors
Mar Vista's U.S. Quality strategy returned +0.20% net-of-fees in Q4 2025. The Russell 1000 Index and the S&P 500 Index returned +2.41% and +2.65%, respectively. Alphabet, Johnson & Johnson and Danaher...
Danaher CEO to Comment on Financial Performance
WASHINGTON, Jan. 12, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") announced that its President and Chief Executive Officer, Rainer M. Blair, will comment tomorrow on the Compan...
The Big 3: BA, DHR, DG
Dan Deming offers a glimpse into companies outside the AI trade he sees rallying in 2026. He offers bullish perspective and example options trades for Boeing (BA), Danaher (DHR), and Dollar General (D...
Danaher Is Ready to Put Its Post-Covid Malaise Behind It
With tariff rules finalized and inventories depleted, there's light at the end of the tunnel for the medical and scientific tools manufacturer.
Danaher to Present at J.P. Morgan Healthcare Conference
WASHINGTON, Jan. 5, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that its President and Chief Executive Officer, Rainer M. Blair, will be presenting at the J.P.
Top 15 High-Growth Dividend Stocks For January 2026
My Top 15 High-Growth Dividend Stock list delivered a 0.83% gain in December, outperforming SPY and VIG. The Value-tilted portfolio variant led with a 2.17% December return, suggesting undervaluation ...
HALPER SADEH LLC ENCOURAGES DANAHER CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
Shareholders should contact the firm immediately as there may be limited time to enforce your rights. NEW YORK , Dec. 24, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is inves...
Danaher Schedules Fourth Quarter 2025 Earnings Conference Call
WASHINGTON , Dec. 17, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the fourth quarter 2025 on Wednesday, January 28, 2...
Danaher: Biotech Strength And Cash Generation Reinforce A $250 Fair Value
Danaher Corporation is rated Buy with a target price of $250, implying 10.5% upside from $226.25. DHR's strong Q3 execution featured 4.5% revenue growth, margin expansion to 37.2%, and robust free cas...
Danaher Announces Quarterly Dividend
WASHINGTON , Dec. 9, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.32 per share of its common st...
3 More Good Stocks to Invest In After Earnings
These cheap stocks from wide-moat companies look attractive today.
Danaher Corporation (DHR) Presents at Jefferies London Healthcare Conference 2025 Transcript
Danaher Corporation ( DHR) Jefferies London Healthcare Conference 2025 November 18, 2025 6:00 AM EST Company Participants Rainer Blair - President, CEO & Director Conference Call Participants Tycho P...
The Big 3: TMO, DHR, VLO
As A.I. stocks take a beating on Wednesday's trading session, Dan Deming offers his thoughts and example options trades in healthcare and energy stocks. He explains his bullish theses behind Thermo Fi...
Danaher to Present at Jefferies Global Healthcare Conference
WASHINGTON , Nov. 11, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the Jefferies Global Healthcare ...
Top 15 High-Growth Dividend Stocks For November 2025
The Top 15 High-Growth Dividend Stock list for November 2025 offers a 1.39% yield and 19.88% five-year dividend growth. Despite underperforming SPY and VIG in October, the watchlist targets a long-ter...
DHR Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher Corporation (NYSE...
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation - DHR
NEW YORK , Oct. 27, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher Co...